BDBM191804 US9187428, 32

SMILES CNC(=O)c1cc(CSc2ncc(C#N)c(-c3ccccc3)c2C#N)ccn1

InChI Key InChIKey=OEBWKIWBLVALPQ-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 191804   

TargetAdenosine receptor A1(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM191804(US9187428, 32)
Affinity DataEC50:  0.400nMpH: 7.4 T: 2°CAssay Description:The following test protocol is used for pharmacologically characterizing cells and for the robot-assisted substance screening:The stock cultures ar...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2b(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM191804(US9187428, 32)
Affinity DataEC50:  2.12E+3nMpH: 7.4 T: 2°CAssay Description:The following test protocol is used for pharmacologically characterizing cells and for the robot-assisted substance screening:The stock cultures ar...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A2a(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM191804(US9187428, 32)
Affinity DataEC50:  3.00E+3nMpH: 7.4 T: 2°CAssay Description:The following test protocol is used for pharmacologically characterizing cells and for the robot-assisted substance screening:The stock cultures ar...More data for this Ligand-Target Pair
In DepthDetails US Patent